Table 3.
Patient characteristics at baseline telehealth encounter (N = 1208 encounters)
| Variable | n | % |
|---|---|---|
| Employed | ||
| Yes | 285 | 24 |
| No | 807 | 67 |
| Unknown | 116 | 9 |
| Insurance status | ||
| Public Insurance | 1061 | 87.8 |
| Uninsured | 141 | 11.7 |
| Private Insurance | 3 | 0.2 |
| Unknown | 3 | 0.2 |
| Area living ina | ||
| Metro | 864 | 72 |
| Small | 165 | 14 |
| Rural | 78 | 6.5 |
| Opioid-related ED encounter | ||
| Yes | 203 | 16.9 |
| No | 1005 | 83.2 |
| Naloxone administered | ||
| Yes | 200 | 16.6 |
| No | 998 | 82.6 |
| Unknown | 10 | 0.8 |
| Route of administration | ||
| Intravenous | 466 | 38.6 |
| Oral ingestion | 432 | 35.8 |
| Inhalation/Snorting | 188 | 15.6 |
| Smoking | 111 | 9.2 |
| Unknown | 11 | 0.9 |
| Peer coach provided referral | ||
| Yes | 902 | 74.7 |
| No | 306 | 25.3 |
| Mean | Standard Deviation | |
| Number ED encounters in previous 365 days | 10.8 | 17.9 |
| Baseline telehealth interaction duration (in minutes) | 22.5 | 21.4 |
aThese categories are not comprehensive and therefore add up to less than 100%